KULR Technology Group (NYSE: KULR), a leader in advanced energy management, has expanded its Bitcoin Treasury with an additional $21 million investment, bringing its total bitcoin acquisitions to $42 million. These purchases were made at an average price of $98,393.58 per bitcoin, including fees and expenses. This move aligns with the company’s Bitcoin Treasury Strategy, […]
MicroCloud Hologram Advances Quantum Technology with High-Fidelity Qubit Control
MicroCloud Hologram (HOLO) has unveiled a groundbreaking advancement in quantum technology: a fast adiabatic driving protocol for achieving coherent control of two heavy hole spin qubits in a double quantum dot (QD) system. This innovative approach surpasses traditional quantum control methods, offering significant improvements in fidelity and stability for quantum information processing. A Leap Beyond […]
MySize Reports Strong Revenue Growth and Expands Global Footprint
MySize, Inc. (NASDAQ: MYSZ), a global leader in AI-powered sizing solutions and omnichannel e-commerce platforms, has released its annual shareholder update, showcasing a year of impressive growth, strategic advancements, and promising future opportunities. Delivering on Revenue and Efficiency MySize projects closing 2024 with $8.5 million in revenue, marking a 23% year-over-year increase. The company attributes […]
Telomir Pharmaceuticals Advances Copper-Binding Research with Telomir-1
Telomir Pharmaceuticals (TELO), a trailblazer in age-reversal research, has announced groundbreaking results demonstrating Telomir-1’s exceptional copper-binding properties. This advancement bolsters the compound’s potential to treat Wilson’s disease, a rare genetic disorder caused by toxic copper accumulation. The findings also expand Telomir’s focus on developing innovative therapies for critical medical challenges. Copper Regulation and Wilson’s Disease […]
Traws Pharma Advances H5N1 Bird Flu Treatment with Promising Data
Traws Pharma (TRAW), a clinical-stage biotech firm focused on respiratory viral diseases, has reported significant progress in the development of its investigational treatment for H5N1 bird flu, tivoxavir marboxil. This breakthrough comes at a time when avian flu is increasingly recognized as a potential global health threat. Dr. Robert R. Redfield, Chief Medical Officer at […]
European Markets Open Higher Amid Holiday Week, Novo Nordisk Rebounds
Markets Begin Festive Week on a Positive Note as Novo Nordisk Recovers From Friday’s Plunge European markets started the week on a positive trajectory, with the pan-European Stoxx 600 index gaining 0.4% in early Monday trading. Most sectors posted gains as investors settled into a shortened trading week ahead of the Christmas holiday. Positive Momentum […]
Why My Size and Taoping Shares Are Soaring
Shares of My Size (NASDAQ: MYSZ) and Taoping Inc. (NASDAQ: TAOP) are experiencing explosive upward momentum today, catching the attention of investors and market watchers. Here’s a closer look at the factors driving these dramatic moves. My Size Soars 400% on Unusual Trading Activity My Size, a company specializing in AI-driven measurement solutions, saw its […]
AmpliTech Group Powers Quantum Computing Revolution with Breakthrough Cryogenic Amplifiers
AmpliTech Group, Inc. (Nasdaq: AMPG) has reached a pivotal milestone with the successful deployment of its proprietary low-noise cryogenic High Electron Mobility Transistor (HEMT) amplifiers. These cutting-edge components are essential for the efficient operation of quantum computers, which require ultra-cold temperatures of 4 Kelvin (-452°F) for high-fidelity quantum operations. AmpliTech has already delivered its cryogenic […]
MIRA Pharmaceuticals Moves Closer to Human Trials for Ketamir-2
MIRA Pharmaceuticals (MIRA), a preclinical-stage pharmaceutical company, has announced promising results from safety studies on Ketamir-2, a novel oral ketamine analog. The findings, which reveal no safety concerns, mark a major milestone as the company prepares for Phase 1 human trials in early 2025. “Advancing Ketamir-2 into clinical trials reflects our dedication to creating a […]
AngioDynamics Secures FDA Clearance for NanoKnife System in Prostate Cancer Treatment
AngioDynamics, Inc. (NASDAQ: ANGO), a leader in medical technology innovation, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting 510(k) clearance for its NanoKnife System for prostate tissue ablation. This clearance marks a pivotal step forward in the treatment of intermediate-risk prostate cancer, offering a minimally invasive option that prioritizes […]